sleep apnea semaglutide Weight-loss drug approved to treat in Canada semaglutide obstructive sleep apnea trial

Most patients achieve 5-15% body weight reduction within six months, with some reaching higher percentages through extended treatment and lifestyle optimization

Lyophilized (freeze-dried) peptides remain stable for years when frozen, whereas pre-mixed liquid formulations rapidly degrade and lose efficacy due to water exposure

It plays multiple roles in glucose homeostasis and appetite regulation

Communicating with Your Healthcare Provider Effective communication is crucial

Results Patient demographics To study perioperative GLP-1 and GLP-2 plasma concentration dynamics, we included 46 patients, undergoing minor (n = 26) or major (n = 20) hepatic resections